WO2007002666A3 - Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant - Google Patents
Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant Download PDFInfo
- Publication number
- WO2007002666A3 WO2007002666A3 PCT/US2006/024968 US2006024968W WO2007002666A3 WO 2007002666 A3 WO2007002666 A3 WO 2007002666A3 US 2006024968 W US2006024968 W US 2006024968W WO 2007002666 A3 WO2007002666 A3 WO 2007002666A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical
- plant
- therapeutic
- derived
- novel
- Prior art date
Links
- 240000006053 Garcinia mangostana Species 0.000 title abstract 3
- 235000017048 Garcinia mangostana Nutrition 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- 241000196324 Embryophyta Species 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 5
- 241000283690 Bos taurus Species 0.000 abstract 2
- 239000002537 cosmetic Substances 0.000 abstract 2
- 238000000605 extraction Methods 0.000 abstract 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 abstract 2
- 230000007407 health benefit Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to pharmaceutical, therapeutic, nutritional, cosmetic, and dermatological compositions derived from the preicarp (rind) of the Garcinia mangostana L plant and the novel extraction processes used to produce those compositions. Specifically, the present invention relates, in part, to an approximately 0.01% to about 80% mixture of a xanthone-rich mangosteen pericarp (rind) extract in novel combinations for pharmaceutical, cosmetic, therapeutic or dermatological compositions that yield surprising health benefits. Additionally, the present invention relates, in part, to novel extraction processes that result in the production of the novel compositions of the invention.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69285405P | 2005-06-22 | 2005-06-22 | |
US60/692,854 | 2005-06-22 | ||
US11/281,302 US20060105069A1 (en) | 2004-11-16 | 2005-11-16 | Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant |
IN1668CH2005 | 2005-11-16 | ||
IN1668/CHE/2005 | 2005-11-16 | ||
US11/281,302 | 2005-11-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007002666A2 WO2007002666A2 (en) | 2007-01-04 |
WO2007002666A3 true WO2007002666A3 (en) | 2007-07-12 |
Family
ID=37595980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/024968 WO2007002666A2 (en) | 2005-06-22 | 2006-06-22 | Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007002666A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080187502A1 (en) | 2007-02-02 | 2008-08-07 | Michelle Garay | Assessment and mitigation of oxidative stress in skin |
FR2917621B1 (en) * | 2007-06-20 | 2009-09-18 | Centre Nat Rech Scient | USE OF OXYGENIC HETEROCYCLES SELECTED AMONG XANTHONES AND BIFLAVONOIDS FOR THE PREPARATION OF A COMPOSITION INTENDED TO ACT AS AN ANTI-COCCIDIAN AGENT |
WO2009093255A2 (en) | 2008-01-21 | 2009-07-30 | Ganga Raju Gokaraju | A new nutraceutical composition from garcinia mangostana |
ITMI20130619A1 (en) * | 2013-04-16 | 2014-10-17 | Variati S R L | NEW COSMETIC ASSOCIATION |
CN103393576B (en) * | 2013-08-07 | 2015-12-23 | 伽蓝(集团)股份有限公司 | A kind of mangosteen extract and application thereof |
CN106361784B (en) * | 2015-07-24 | 2020-08-14 | 山酮新药开发股份有限公司 | Use of mangosteen husk extract for the treatment of skin diseases |
CN105168478A (en) * | 2015-08-28 | 2015-12-23 | 无限极(中国)有限公司 | Skin care product and preparation method thereof |
KR102160798B1 (en) * | 2017-05-23 | 2020-09-29 | 동국대학교 산학협력단 | Composition comprising extract of Garcinia Mangostana or xanthone compounds derived from for treating or preventing porcine epidemic diarrhea |
US20210353701A1 (en) * | 2018-11-02 | 2021-11-18 | Shiseido Company, Ltd. | Ultraviolet light-induced inflammation suppressing agent comprising alternative autophagy inducing agent |
CN113816936B (en) * | 2020-06-19 | 2023-05-02 | 广州长峰生物技术有限公司 | Mangostin derivative compound and preparation method and application thereof |
CN113620967B (en) * | 2021-07-31 | 2023-01-06 | 广州中医药大学(广州中医药研究院) | Alpha-mangostin derivative and preparation method and application thereof |
CN113717144B (en) * | 2021-09-24 | 2023-04-11 | 湖南朗林生物资源股份有限公司 | Method for extracting alpha-mangostin and gamma-mangostin from mangosteen |
WO2023077397A1 (en) * | 2021-11-05 | 2023-05-11 | Xantho Biotechnology Co., Ltd | Use of mangosteen fruit shell extract in the preparation of a medicament for treating psoriasis |
FR3134313B1 (en) * | 2022-04-07 | 2024-04-05 | Fabre Pierre Dermo Cosmetique | Combination of a Garcinia mangostana extract and fresh Avena sativa juice to fight against inflammation induced by C. acnes |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5306486A (en) * | 1993-03-01 | 1994-04-26 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic sunscreen composition containing green tea and a sunscreen |
US20030138467A1 (en) * | 2001-12-27 | 2003-07-24 | Avon Products, Inc. | Methods for improving the aesthetic appearance of skin |
US20030175237A1 (en) * | 2002-02-26 | 2003-09-18 | Bailey William L. | Method for the reduction of fasting plasma glucose and hemoglobin AIC levels |
-
2006
- 2006-06-22 WO PCT/US2006/024968 patent/WO2007002666A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5306486A (en) * | 1993-03-01 | 1994-04-26 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic sunscreen composition containing green tea and a sunscreen |
US20030138467A1 (en) * | 2001-12-27 | 2003-07-24 | Avon Products, Inc. | Methods for improving the aesthetic appearance of skin |
US20030175237A1 (en) * | 2002-02-26 | 2003-09-18 | Bailey William L. | Method for the reduction of fasting plasma glucose and hemoglobin AIC levels |
Also Published As
Publication number | Publication date |
---|---|
WO2007002666A2 (en) | 2007-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007002666A3 (en) | Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant | |
WO2007067495A3 (en) | Levodopa prodrug mesylate, compositions thereof, and uses thereof | |
WO2007109210A3 (en) | Extracts and methods comprising curcuma species | |
WO2006099169A3 (en) | Novel liposome compositions | |
MY142017A (en) | Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same | |
WO2004035629A8 (en) | Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives | |
WO2005046575A3 (en) | Amino acid prodrugs | |
MX2009011869A (en) | Liquorice extract antimicrobial and anti-inflammatory isolates. | |
WO2009019534A3 (en) | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | |
WO2008148873A3 (en) | Hydroxyproline compositions and uses thereof | |
WO2008030818A3 (en) | Novel liposome compositions | |
WO2006034154A3 (en) | Salts of 5-azacytidine | |
WO2006138608A3 (en) | Pharmaceutical compositions and use thereof | |
PT1594833E (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
WO2006078699A3 (en) | Oral care compositions derived from the labiatae family | |
SG114627A1 (en) | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract | |
WO2007113291A3 (en) | Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same | |
GEP20115332B (en) | Herbal composition for inflammatory disorders | |
WO2007048398A3 (en) | Preparation and use of a phytotherapeutic agent | |
ATE452120T1 (en) | FATTY ACID BENZENEDIOL DERIVATIVES AND PRODUCTION AND USE PROCESSES THEREOF | |
MX2011008261A (en) | Pharmaceutical compositions comprising tgf- î²1 inhibitor peptides. | |
WO2004033448A3 (en) | Isolation, purification and synthesis of procyanidin b2 and uses thereof | |
WO2008135661A3 (en) | Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation | |
CY1110401T1 (en) | PRODUCTION OF 1-PHENYLCOCARCAROXYLIC ACIDS FOR TREATMENT OF NEUROCOLOGICAL DISEASES | |
WO2007083006A3 (en) | Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06774096 Country of ref document: EP Kind code of ref document: A2 |